What are the main markets for this product?

Products are exported to over 80 countries in Asia, the Americas, Europe, Oceania, and Africa.

What are the available payment terms?

The company accepts LC (Letter of Credit) and T/T (Telegraphic Transfer) as payment terms.

What is the lead time during peak season?

The average lead time during peak season is one month.

Glucose 5% Intravenous Infusion GMP Manufacturer

Name: Glucose 5% Intravenous Infusion GMP Manufacturer
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 741108572

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.15-0.20

20,000 Pieces

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Injection

Model NO.

100ml~1L

Suitable for

Elderly, Adult

State

Liquid

Shape

Injection

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

13022474

Production Line

GMP Approval

Transport Package

Carton

Specification

100ml~1000ml

Trademark

SHIMEN

Origin

Hebei

HS Code

3004909099

Production Capacity

1000000

Key features

GMP Certified Production: Manufactured in strict accordance with GMP requirements using fully automated production lines.

Heat Source & Hypoglycemia Treatment: Provides 16.7kJ heat per gram; used for heat supplementation and treating hypoglycemia.

Hyperpotassemia Management: Facilitates potassium entry into cells when administered with drugs to lower plasma potassium levels.

Dehydrating Agent: Fast intravenous administration helps treat tissue dehydration.

Osmotic Pressure Regulation: Main material for maintaining and adjusting osmotic pressure in peritoneal dialysate.

Global Market Reach: Products exported to over 80 countries across Asia, Americas, Europe, Oceania, and Africa.

Leading Manufacturer Status: Top 100 pharmaceutical enterprise in China with 70 years of business history.

Advanced Automation: Production lines feature full automation and information control at international advanced levels.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤11.71hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is identified as a Chinese public pharmaceutical manufacturer based in Hebei, with products spanning infusion solutions, injections, tablets, capsules, inhalation products, and other medical materials. The supplier reports ISO 9001, ISO 14001, and GMP certifications, more than ten production lines, automated and information-based production and logistics processes, and substantial stated output across several dosage forms. Its export activity began in 2002, although exports represent only 1%–10% of total sales. The company describes integrated R&D, manufacturing, and marketing capabilities, but the provided information does not establish specific after-sales programs, customization services, or named customer cases. Financial strength cannot be assessed because financial data is excluded.

Supplier typeThe supplier is explicitly classified as a Manufacturer/Factory and is described as an integrated pharmaceutical enterprise covering R&D, industrial production, and marketing. Its listed business covers health and medicine products, including injections, infusion solutions, tablets, capsules, and related dosage forms.

CertificationsThe supplier reports ISO 9001, ISO 14001, and GMP certifications. It also states that production is organized strictly according to GMP requirements, providing explicit evidence of formal quality, environmental, and pharmaceutical manufacturing systems.

R&D capabilityThe supplier describes an integrated R&D, production, and marketing model, reports 50 R&D engineers, and states that its production lines integrate leading equipment and technology at an international advanced level. This supports established technical and development capability, although no specific patents, new-product results, or R&D investment details are provided.

Production capacityProduction capability is strongly supported by more than ten production lines, automated and information-based production and logistics processes, and stated annual outputs of 1.5 billion large-volume injection units and 1 billion units each for tablets, capsules, and small-volume injections. The company also reports more than ten international advanced infusion-solution lines and exports through both agency and self-operated channels.

Product Q&A

Q:What is the primary function of Glucose 5% Injection?

It serves as a heat source for the human body, treats hypoglycemia, manages hyperpotassemia, acts as a dehydrating agent, and regulates osmotic pressure in dialysate.

Q:Is the production process GMP compliant?

Yes, the product is manufactured in strict accordance with GMP requirements using fully automated production lines.

Q:How much heat does one gram of glucose produce?

One gram of glucose can produce 16.7kJ of heat.

Q:What is the physical appearance of the product?

The product is a colorless or almost colorless clear liquid with a sweet flavor.

Q:Where is the manufacturer located?

The manufacturer, Shijiazhuang No. 4 Pharmaceutical Co., Ltd., is located in Shijiazhuang, Hebei, China.